Matthew K. Szot - 18 Jan 2024 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVKD	Stock Options	Award	$0	+250,000		$0.000000	250,000	18 Jan 2024	Common Stock	250,000	$0.9400	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.